Mainstay Medical receives new patent for ReActiv8 system: 4 things to know

Mainstay Medical announced the issuance of a new United States patent.

Advertisement

Here are four things to know:

 

1. The patent issued is entitled “Apparatus and Methods for Rehabilitating a Muscle And Assessing Progress of Rehabilitation.”

 

2. The patent was issued in related to its ReActiv8 system.

 

3. The system is an implantable neurostimulation system designed to treat disabling chronic low back pain.

 

4. Mainstay Medical is a medical device company headquartered in Dublin, Ireland. It also has subsidiaries operating in Ireland, the United States and Australia.

 

More articles on devices:
Xtant Medical receives FDA clearance for demineralized bone matrix putty: 4 observations
Wireless sensors in orthopedic implants may detect SSIs — 4 things to know
Prosthetic market faces reimbursement challenges — 5 things to know

At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.

Advertisement

Next Up in Spinal Tech

Advertisement

Comments are closed.